Mkts

Emergent BioSolutions Inc.

NYSE: EBS
$6.23+0.00 (+0.00%)
As of Oct 23, 4:00 PM ET

Key statistics

Day range
6.016.25
52-week range
4.3614.06
Today
Open6.20
Previous close6.23
Volume—
Valuation
Market cap319.43M
P/E ratio—
EPS (TTM)-3.51
Income & risk
Dividend / yield—
Beta2.43
Avg volume1.12M
Discussion

EBS News

Stories mentioning EBS from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue156,100148,700231,100140,900222,200194,700293,800254,700
Cost of Goods Sold72,00084,90085,90066,90088,500118,000122,600296,100
Gross Profit84,10063,800145,20074,000133,700101,300161,200(48,000)
Operating Expenses
Research & Development10,50012,10013,50012,50015,1009,10013,80032,700
Sales General & Admin46,60051,10038,90043,70052,40060,80076,60085,900
Total Operating Expenses
Operating Income (Loss)10,500(27,900)76,5001,60049,900(9,500)64,500(203,500)
Interest Income
Interest Expense
Other Expense13,900(8,100)(3,700)(3,700)69,700(3,900)21,900(2,700)
Pretax Income13,400(50,700)57,600(16,800)92,700(27,600)142,400(269,800)
Tax Provision6,6003,9006,400(4,800)24,7003,70027,60013,300
Net Income (Loss)6,800(54,600)51,200(12,000)68,000(31,300)114,800(283,100)
Earnings Per Share (Basic)0.13(1.02)0.96(0.22)1.25(0.59)2.16(5.38)
Earnings Per Share (Diluted)0.07(0.96)0.91(0.22)1.19(0.59)2.06(5.38)
Weighted Average Shares Outstanding (Basic)51,90053,50053,20054,20054,40053,00053,10052,600
Weighted Average Shares Outstanding (Diluted)56,50056,70056,50054,20057,30053,00055,60052,600

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About EBS

Emergent BioSolutions Inc. (NYSE: EBS) is a stock listed on the New York Stock Exchange under the ticker symbol EBS. It last traded at $6.23 (Oct 23, 2026, 4:00 PM ET), unchanged on the day. That gives Emergent BioSolutions a market capitalisation of $319.4M.

Over the past 52 weeks EBS has traded between $4.36 and $14.06.

Revenue for the quarter ended Mar 31, 2026 was $156.1M; net income $6.8M. Revenue was down 29.7% from $222.2M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$156.1M$6.8M4.4%
Dec 31, 2025$148.7M-$54.6M-36.7%
Sep 30, 2025$231.1M$51.2M22.2%
Jun 30, 2025$140.9M-$12.0M-8.5%

From Emergent BioSolutions’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…